Latest Prognosis Stories
SAN DIEGO, Feb. 22, 2011 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today that it has received New York State approval for its proprietary PROMETHEUSÂ® Crohn's Prognostic test.
CAMBRIDGE, Mass. and BRANFORD, Conn., Dec.
A new study finds that families of people who are critically ill may have a more hopeful view their loved oneâ€™s condition than do doctors, even when doctors provide survival estimates.
Almost 60 mantle cell lymphoma (MCL) specialists from around the world gathered in Atlanta, GA for the Lymphoma Research Foundation's (LRF) Sixth Annual Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop.
Critically ill patients often have uncertain prognoses but families overwhelmingly wish physicians would address uncertainty candidly, U.S.
A study published on Monday suggests that although many doctors worry about breaking bad news about seriously ill patients to their kin, most family members want to know the truth.
Cypress Bioscience, Inc. (NASDAQ: CYPB) will launch its first two novel personalized medicine services at the American College of Rheumatology Annual Scientific Meeting in San Francisco on October 24-29, 2008.
US-based Health Discovery Corporation has signed a licensing agreement with Smart Personalized Medicine founded by Richard Caruso, chairman and founder of Intergra Life Sciences.
Health Discovery Corporation ("HDC") (OTCBB: HDVY) today announced that it has signed a Licensing Agreement with Smart Personalized Medicine, LLC, founded by Dr.
Mayo Clinic neurologists have created the first new, reliable and easy-to-use clinical tool in 30 years for measuring coma depth, a proposed replacement for the Glasgow Coma Scale. The new scoring system, called the FOUR (Full Outline of UnResponsiveness) Score, will be described in the October issue of Annals of Neurology, to be published online Friday, Sept. 9.
- A poem in which the author retracts something said in an earlier poem.